Buspirone vs. Bupropion: What’s the Difference and Which Is Right for You?

Buspirone and bupropion have similar-sounding names, and both are commonly prescribed psychiatric medications, but they are quite different in how they work, what they treat, and who they are best suited for. Understanding the distinctions can help you have a more productive conversation with your psychiatrist about your options.

Key Takeaways

• Buspirone is FDA-approved specifically for generalized anxiety disorder (GAD); bupropion is FDA-approved for major depressive disorder, seasonal affective disorder, and smoking cessation. The two medications work through entirely different brain pathways: buspirone acts on serotonin receptors, while bupropion inhibits the reuptake of dopamine and norepinephrine.

• In some cases, providers prescribe both together, bupropion for depression and buspirone for anxiety, because they can complement each other, especially when one condition is worsening the other.

What Is Buspirone?

Buspirone (formerly sold as BuSpar) is an FDA-approved medication used to treat anxiety. It works by gently adjusting serotonin activity in the brain, which can help calm the overactive stress signals linked to anxiety. Unlike benzodiazepines, it doesn’t work on GABA receptors and is less likely to cause sedation or dependence. For generalized anxiety disorder, the usual starting dose is 15 mg per day. This is typically taken as 7.5 mg twice daily or 5 mg three times a day.

Key clinical characteristics of buspirone:

• FDA-approved for generalized anxiety disorder and short-term anxiety relief

• Non-habit-forming, with no dependence or withdrawal risk comparable to benzodiazepines

• Does not cause sedation, cognitive impairment, or weight gain

• Takes two to four weeks for anxiety relief to fully develop

• Used off-label as an augmentation agent for depression, particularly alongside selective serotonin reuptake inhibitors (SSRIs)

What Is Bupropion?

Bupropion (sold as Wellbutrin, Forfivo XL, and Zyban) is a different type of antidepressant. Instead of mainly affecting serotonin, it increases dopamine and norepinephrine — brain chemicals linked to energy, motivation, and focus. Because of this, it can be especially helpful for people whose depression comes with low energy, fatigue, or trouble concentrating. The once-daily dosage form ranges from 75 mg to 522 mg.

Key clinical characteristics of bupropion:

• FDA-approved for major depressive disorder, seasonal affective disorder, and smoking cessation (as Zyban)

• Also approved as a component of Contrave (with naltrexone) for weight management

• Tends to be activating rather than sedating, which distinguishes it from most antidepressants

• Does not cause sexual dysfunction or weight gain (and may cause modest weight loss)

• Not FDA-approved for anxiety, though sometimes used off-label when anxiety co-occurs with depression

• Carries a seizure risk at higher doses, particularly in people with eating disorders or a history of seizures

Buspirone vs. Bupropion: Quick Comparison

FDA Approvals: What Each Medication Is Used For

This distinction matters in practice. Buspirone is FDA-approved for anxiety; bupropion is not. Bupropion is sometimes used off-label for anxiety, but the evidence base is more limited, and the results are mixed.

 Data show that in clinical trials for bupropion, 5–6% of participants reported increased anxiety while taking the medication, compared to 3% in the placebo group. Bupropion's activating, dopamine-boosting profile can actually worsen anxiety in some patients, which is why it is generally not the first choice for anxiety disorders.

Buspirone, by contrast, has a well-established evidence base for generalized anxiety disorder. Buspirone at 15–30 mg per day produced anxiety relief comparable to benzodiazepines without the associated risks. It has also demonstrated benefit in patients with co-occurring depression alongside anxiety.

When Providers Prescribe Buspirone and Bupropion Together

Because buspirone targets anxiety and bupropion targets depression, they can be a logical combination when both conditions are present. Research shows that more than 40% of people with depression also experience an anxiety disorder.

The combination can make particular clinical sense when:

• Bupropion's activating, dopamine-energizing effect worsens underlying anxiety; buspirone can counteract this

• A patient's primary complaint is depression with fatigue and low motivation (bupropion), alongside chronic worry and tension (buspirone)

• A patient on an SSRI is switching to bupropion but needs ongoing anxiolytic coverage during the transition

The STAR*D trial, a majorstudy, found evidence supporting buspirone as an augmentation agent alongside antidepressants for treatment-resistant depression.

Side Effect Profiles

Buspirone's side effect profile is generally considered milder. The most common early effects include dizziness, nausea, and headache, which tend to resolve within one to two weeks. Notably, it does not cause sexual dysfunction, weight gain, sedation, or cognitive impairment.

Bupropion's side effect profile is more varied. Dry mouth, headache, insomnia, and agitation are the most common. The activating quality that makes it useful for depression-related fatigue can also interfere with sleep and, in some patients, increase anxiety. The most serious concern is seizure risk, which is low at recommended doses but increases at higher doses and in patients with specific risk factors (eating disorders, seizure history, significant alcohol use).

Neither medication causes dependence, and neither is associated with the significant withdrawal syndromes seen with benzodiazepines or SSRIs.

Choosing Between Buspirone or Bupropion: Questions to Ask Your Provider

Neither medication is universally "better." The right choice depends on your specific situation. Here are a few helpful questions you might want to discuss with your psychiatrist:

• What are my main symptoms? Are they mostly anxiety, depression, or a mix of both?

• Do I have a history of seizures or eating disorders? This is important because it can affect whether bupropion is a safe option, especially at higher doses.

• Am I currently taking an SSRI? If so, medications like buspirone might sometimes be added to boost effectiveness or help with side effects like sexual dysfunction.

• Are fatigue and low motivation major parts of my depression? If they are, bupropion’s more energizing effect might be helpful.

• Am I worried about weight gain or sexual side effects? Both medications tend to be more favorable in these areas compared with some other antidepressants.

If anxiety is your main concern, it can help to check whether your insurance plan covers anxiety treatment so you know what services may be available to you. If you’re seeking care for depression, reviewing whether depression treatment is covered by insurance can give you similar clarity about your coverage and options.

How do I find the right medication for my symptoms? 

A board-certified psychiatrist can look at your full set of symptoms and medical history to help figure out the treatment approach that fits you best. Platforms like Blossom Health make it easy to connect with licensed psychiatric providers for virtual, in-network care, often with appointments available within days. If you’re unsure whether it’s the right step, learning more about what a psychiatrist does and when to see one can help you decide.

Medical Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified healthcare provider with questions about your medication. If you are experiencing a mental health crisis, call or text 988.

Sources

1. NCBI StatPearls. Buspirone. https://www.ncbi.nlm.nih.gov/books/NBK531477/ 

2. NCBI StatPearls. Bupropion. https://www.ncbi.nlm.nih.gov/books/NBK470212/ 

3. Goa KL, Ward A. Buspirone. 1986. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs. https://pubmed.ncbi.nlm.nih.gov/2874976/

4. Woo YS et al. 2025. Effectiveness of Buspirone in Alleviating Anxiety Symptoms in Patients with Depressive Disorder: A Multicenter Prospective Observational Study in Korea. Clin Psychopharmacol Neurosci. https://pmc.ncbi.nlm.nih.gov/articles/PMC11747738/ 

5. Buspirone vs. Bupropion. SingleCare. https://www.singlecare.com/blog/buspirone-vs-bupropion/ 

6. FDA Prescribing Information. BuSpar (buspirone HCl). https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018731s051lbl.pdf 

7. NAMI. Bupropion (Wellbutrin). https://www.nami.org/treatments-and-approaches/mental-health-medications/types-of-medication/bupropion-(wellbutrin/ 

8. Rakel RE. 1990. Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety. South Med J. https://pubmed.ncbi.nlm.nih.gov/2406933/  

9. NIMH. Anxiety Disorders. https://www.nimh.nih.gov/health/topics/anxiety-disorders 

10. NIMH. Depression. https://www.nimh.nih.gov/health/topics/depression